Matches in Nanopublications for { ?s ?p "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293559.RALat0QZtdkGjpxtzDqYlotDvnZxhevJI6XHDbkUVEs4w130_assertion description "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293559.RALat0QZtdkGjpxtzDqYlotDvnZxhevJI6XHDbkUVEs4w130_provenance.
- NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_assertion description "[Combination therapy with BRAF and MEK inhibitors is a recommended treatment strategy for metastatic melanoma patients with BRAF(V600) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293560.RA6tK3Uw3EU8UFBK5KIADHVy_63OWygNn7L10NxV_Hubo130_provenance.